drugset / Trial / NCT05226351

Activation of the Endocannabinoid System and Cognition

NCT05226351

Completed 192 enrolled Charite University, Berlin, Germany
RandomizedFactorialDouble-blindOther

Summary

Recent data suggest that the cannabinoid-system is involved in stress regulation and posttraumatic stress disorder (PTSD). Low endocannabinoid signaling has been found in PTSD patients and might even present a precondition to develop PTSD after trauma. The aim of the current project is to investigate the impact of an activation of the cannabinoid system with an exogenous cannabinoid (dronabinol, i.e., delta-9-tetrahydrocannabinol) on fear conditioning.

Timeline

Start
2022-03-01
Primary completion
2024-08-15
Completion
2024-08-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dronabinol Other / unclassified 2.5 mg Oral